MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on March 13, 2006; DOI: 10.1124/mol.106.023259


0026-895X/06/7001-16-22$20.00
Mol Pharmacol 70:16-22, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.023259v1
70/1/16    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in MolPharm
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McLaughlin, J. T.
Right arrow Articles by Rosenberg, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McLaughlin, J. T.
Right arrow Articles by Rosenberg, R. L.

Role of the Outer beta-Sheet in Divalent Cation Modulation of {alpha}7 Nicotinic Receptors

James T. McLaughlin, Jie Fu, Adrian D. Sproul1, and Robert L. Rosenberg

Departments of Pharmacology (J.T.M., J.F., A.D.S., R.L.R.) and Cell & Molecular Physiology (R.L.R.), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

{alpha}-7 Nicotinic acetylcholine receptors (AChRs) exhibit a positive modulation by divalent cations similar to that observed in other AChRs. In the chick {alpha}7 AChR, this modulation involves a conserved glutamate in loop 9 (Glu172) that undergoes agonist-dependent movements during activation. From these observations, we hypothesized that movements of the nearby beta-sheet formed by the beta7, beta9, and beta10 strands may be involved in agonist activation and/or divalent modulation. To test this hypothesis, we examined functional properties of cysteine mutations of the beta7 and beta10 strands, alone or in pairs. We postulated that reduced flexibility or mobility of the beta7/beta9/beta10-sheet as a result of introduction of a disulfide bond between the beta strands would alter activation by agonists. Using a nondesensitizing {alpha}7 mutant background (L247T), we identified one mutant pair, K144C + T198C, that exhibited a unique characteristic: it was fully activated by divalent cations (Ca2+, Ba2+, or Sr2+) in the absence of acetylcholine (ACh). Divalent-evoked currents were blocked by the {alpha}7 antagonist methyllycaconitine and were abolished when Glu172 was mutated to glutamine. When the K144C + T198C pair was expressed in wild-type {alpha}7 receptors, activation required both ACh and divalent cations. We conclude that the introduction of a disulfide bond into beta7/beta9/beta10 lowers the energetic barrier between open and closed conformations, probably by reducing the torsional flexibility of the beta-sheet. In this setting, divalent cations, acting at the conserved glutamate in loop 9, act as full agonists or requisite coagonists.


Received for publication February 7, 2006.

Accepted for publication March 13, 2006.

Address correspondence to: Dr. James T. McLaughlin, Department of Pharmacology, CB# 7365, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365. E-mail: jmclaughlin{at}unc.edu


Related articles in MolPharm:

Potentiation of Acetylcholine Receptors by Divalent Cations
Jon Lindstrom
MolPharm 2006 70: 5-7. [Abstract] [Full Text]  



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
S. C. Barron, J. T. McLaughlin, J. A. See, V. L. Richards, and R. L. Rosenberg
An Allosteric Modulator of {alpha}7 Nicotinic Receptors, N-(5-Chloro-2,4-dimethoxyphenyl)-N'-(5-methyl-3-isoxazolyl)-urea (PNU-120596), Causes Conformational Changes in the Extracellular Ligand Binding Domain Similar to Those Caused by Acetylcholine
Mol. Pharmacol., August 1, 2009; 76(2): 253 - 263.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Bertrand, S. Bertrand, S. Cassar, E. Gubbins, J. Li, and M. Gopalakrishnan
Positive Allosteric Modulation of the {alpha}7 Nicotinic Acetylcholine Receptor: Ligand Interactions with Distinct Binding Sites and Evidence for a Prominent Role of the M2-M3 Segment
Mol. Pharmacol., November 1, 2008; 74(5): 1407 - 1416.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. P. Venkatachalan and C. Czajkowski
A conserved salt bridge critical for GABAA receptor function and loop C dynamics
PNAS, September 9, 2008; 105(36): 13604 - 13609.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
E. A. Gay and J. L. Yakel
Gating of nicotinic ACh receptors; new insights into structural transitions triggered by agonist binding that induce channel opening
J. Physiol., November 1, 2007; 584(3): 727 - 733.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. T. McLaughlin, J. Fu, and R. L. Rosenberg
Agonist-Driven Conformational Changes in the Inner beta-Sheet of {alpha}7 Nicotinic Receptors
Mol. Pharmacol., May 1, 2007; 71(5): 1312 - 1318.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Tsuneki, S. Kobayashi, K. Takagi, S. Kagawa, M. Tsunoda, M. Murata, T. Matsuoka, T. Wada, M. Kurachi, I. Kimura, et al.
Novel G423S Mutation of Human {alpha}7 Nicotinic Receptor Promotes Agonist-Induced Desensitization by a Protein Kinase C-Dependent Mechanism
Mol. Pharmacol., March 1, 2007; 71(3): 777 - 786.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Lindstrom
Potentiation of Acetylcholine Receptors by Divalent Cations
Mol. Pharmacol., July 1, 2006; 70(1): 5 - 7.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics